glp-1 for obesity madisonville Who Gets the Shot? Access by State Use of diabetes and anti-obesity

Paul Hrkal, your host

While it appears to be well-tolerated for treatment cycles lasting several weeks to months, the effects of continuous, prolonged use are not yet known

Currently, two GLP-1 medications are FDA-approved specifically for weight loss: Wegovy (semaglutide) and Zepbound (tirzepatide)

57 Neurological Effects of GLP-1RAs in Patients With Diabetes Mellitus In 46 patients with T2D with diabetic peripheral neuropathy, randomized in parallel groups to exenatide versus insulin glargine over 18 months, there was no change in confirmed clinical neuropathy, intraepidermal nerve fiber density, or measures of cardiovascular autonomic neuropathy (NCT00855439)